Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$306.88 - $380.0 $460,320 - $570,000
-1,500 Reduced 2.5%
58,500 $22.1 Million
Q3 2023

Nov 09, 2023

BUY
$315.92 - $397.36 $2.27 Million - $2.86 Million
7,200 Added 13.64%
60,000 $19.1 Million
Q2 2023

Aug 11, 2023

SELL
$346.15 - $392.09 $5.26 Million - $5.96 Million
-15,200 Reduced 22.35%
52,800 $20.2 Million
Q1 2023

May 11, 2023

BUY
$323.56 - $373.36 $6.79 Million - $7.84 Million
21,000 Added 44.68%
68,000 $25.4 Million
Q4 2022

Feb 13, 2023

BUY
$248.67 - $334.17 $24,369 - $32,748
98 Added 0.21%
47,000 $15.5 Million
Q3 2022

Nov 14, 2022

BUY
$263.81 - $337.27 $2.61 Million - $3.34 Million
9,902 Added 26.76%
46,902 $12.8 Million
Q2 2022

Aug 12, 2022

SELL
$301.4 - $428.42 $2.71 Million - $3.86 Million
-9,000 Reduced 19.57%
37,000 $11.6 Million
Q1 2022

May 13, 2022

SELL
$379.46 - $424.54 $3.13 Million - $3.51 Million
-8,260 Reduced 15.22%
46,000 $19.2 Million
Q4 2021

Feb 11, 2022

BUY
$373.53 - $434.12 $3.46 Million - $4.02 Million
9,260 Added 20.58%
54,260 $23 Million
Q2 2021

Aug 13, 2021

SELL
$372.36 - $412.07 $1.86 Million - $2.06 Million
-5,000 Reduced 10.0%
45,000 $17.8 Million
Q1 2021

May 14, 2021

SELL
$357.26 - $392.57 $1.79 Million - $1.96 Million
-5,000 Reduced 9.09%
50,000 $19.2 Million
Q4 2020

Jan 19, 2021

SELL
$319.05 - $363.32 $1.6 Million - $1.82 Million
-5,000 Reduced 8.33%
55,000 $20 Million
Q3 2020

Oct 13, 2020

BUY
$280.08 - $347.78 $5.6 Million - $6.96 Million
20,000 Added 50.0%
60,000 $20.2 Million
Q2 2020

Jul 16, 2020

BUY
$270.93 - $320.3 $4.33 Million - $5.12 Million
16,000 Added 66.67%
40,000 $11.3 Million
Q1 2020

Apr 16, 2020

BUY
$243.44 - $359.98 $973,760 - $1.44 Million
4,000 Added 20.0%
24,000 $6.62 Million
Q4 2019

Jan 17, 2020

BUY
$281.18 - $322.05 $5.62 Million - $6.44 Million
20,000 New
20,000 $6.43 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.